Bone erosion: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Bone erosion | |||
| image = [[File:X-ray_of_right_fourth_PIP_joint_with_bone_erosions_by_rheumatoid_arthritis.jpg|left|thumb|X-ray of right fourth PIP joint with bone erosions by rheumatoid arthritis]] | |||
| caption = X-ray showing bone erosion in the proximal interphalangeal joint due to [[rheumatoid arthritis]]. | |||
| field = [[Rheumatology]] | |||
| synonyms = | |||
| symptoms = Joint pain, swelling, stiffness | |||
| complications = Joint deformity, loss of function | |||
| onset = Gradual | |||
| duration = Chronic | |||
| causes = [[Rheumatoid arthritis]], [[psoriatic arthritis]], [[gout]], [[osteomyelitis]] | |||
| risks = Genetic predisposition, smoking, obesity | |||
| diagnosis = [[X-ray]], [[MRI]], [[ultrasound]] | |||
| differential = [[Osteoarthritis]], [[osteoporosis]] | |||
| prevention = Early treatment of underlying conditions | |||
| treatment = [[Disease-modifying antirheumatic drugs]] (DMARDs), [[biologics]], [[corticosteroids]], [[physical therapy]] | |||
| medication = [[Methotrexate]], [[adalimumab]], [[prednisone]] | |||
| prognosis = Variable, depends on underlying condition and treatment | |||
| frequency = Common in patients with inflammatory arthritis | |||
}} | |||
== Bone Erosion == | == Bone Erosion == | ||
[[File:X-ray_of_right_fourth_PIP_joint_with_bone_erosions_by_rheumatoid_arthritis.jpg|X-ray of right fourth PIP joint with bone erosions by rheumatoid arthritis|left|thumb]] | |||
[[File:X-ray_of_right_fourth_PIP_joint_with_bone_erosions_by_rheumatoid_arthritis.jpg|X-ray of right fourth PIP joint with bone erosions by rheumatoid arthritis|thumb | |||
'''Bone erosion''' refers to the loss of bone tissue, typically occurring in the context of [[inflammatory]] conditions such as [[rheumatoid arthritis]] (RA). It is characterized by the destruction of the bone surface, leading to structural damage and potential functional impairment. | '''Bone erosion''' refers to the loss of bone tissue, typically occurring in the context of [[inflammatory]] conditions such as [[rheumatoid arthritis]] (RA). It is characterized by the destruction of the bone surface, leading to structural damage and potential functional impairment. | ||
== Pathophysiology == | == Pathophysiology == | ||
Bone erosion is primarily driven by an imbalance between bone resorption and bone formation. In healthy bone, [[osteoclasts]] and [[osteoblasts]] work in harmony to remodel bone tissue. However, in pathological conditions, this balance is disrupted, often due to inflammatory processes. | Bone erosion is primarily driven by an imbalance between bone resorption and bone formation. In healthy bone, [[osteoclasts]] and [[osteoblasts]] work in harmony to remodel bone tissue. However, in pathological conditions, this balance is disrupted, often due to inflammatory processes. | ||
In rheumatoid arthritis, for example, the [[synovial membrane]] becomes inflamed, leading to the production of pro-inflammatory cytokines such as [[tumor necrosis factor-alpha]] (TNF-α) and [[interleukin-1]] (IL-1). These cytokines stimulate osteoclastogenesis, the process by which osteoclasts are formed, leading to increased bone resorption and subsequent erosion. | |||
In rheumatoid arthritis, for example, the [[synovial membrane]] becomes inflamed, leading to the production of pro-inflammatory cytokines such as [[tumor necrosis factor-alpha]] (TNF- | |||
== Clinical Presentation == | == Clinical Presentation == | ||
Patients with bone erosion may present with joint pain, swelling, and stiffness. Over time, the structural integrity of the affected bones can be compromised, leading to deformities and loss of function. In rheumatoid arthritis, common sites of bone erosion include the small joints of the hands and feet. | Patients with bone erosion may present with joint pain, swelling, and stiffness. Over time, the structural integrity of the affected bones can be compromised, leading to deformities and loss of function. In rheumatoid arthritis, common sites of bone erosion include the small joints of the hands and feet. | ||
== Diagnosis == | == Diagnosis == | ||
Bone erosion is typically diagnosed using imaging techniques. [[X-ray]] is a common modality used to visualize bone erosions, as it can reveal changes in bone structure and density. More advanced imaging techniques, such as [[magnetic resonance imaging]] (MRI) and [[ultrasound]], can provide more detailed information about the extent of erosion and associated soft tissue changes. | Bone erosion is typically diagnosed using imaging techniques. [[X-ray]] is a common modality used to visualize bone erosions, as it can reveal changes in bone structure and density. More advanced imaging techniques, such as [[magnetic resonance imaging]] (MRI) and [[ultrasound]], can provide more detailed information about the extent of erosion and associated soft tissue changes. | ||
== Management == | == Management == | ||
The management of bone erosion involves addressing the underlying inflammatory condition. In rheumatoid arthritis, disease-modifying antirheumatic drugs (DMARDs) such as [[methotrexate]] are commonly used to reduce inflammation and slow the progression of bone damage. Biologic agents targeting specific cytokines, such as TNF inhibitors, can also be effective in preventing further erosion. | The management of bone erosion involves addressing the underlying inflammatory condition. In rheumatoid arthritis, disease-modifying antirheumatic drugs (DMARDs) such as [[methotrexate]] are commonly used to reduce inflammation and slow the progression of bone damage. Biologic agents targeting specific cytokines, such as TNF inhibitors, can also be effective in preventing further erosion. | ||
== Prevention == | == Prevention == | ||
Preventing bone erosion involves early diagnosis and aggressive treatment of the underlying inflammatory condition. Regular monitoring with imaging studies can help assess the effectiveness of treatment and guide adjustments in therapy. | Preventing bone erosion involves early diagnosis and aggressive treatment of the underlying inflammatory condition. Regular monitoring with imaging studies can help assess the effectiveness of treatment and guide adjustments in therapy. | ||
== See also == | |||
== | |||
* [[Rheumatoid arthritis]] | * [[Rheumatoid arthritis]] | ||
* [[Osteoclast]] | * [[Osteoclast]] | ||
| Line 28: | Line 40: | ||
* [[Synovial membrane]] | * [[Synovial membrane]] | ||
* [[Tumor necrosis factor-alpha]] | * [[Tumor necrosis factor-alpha]] | ||
[[Category:Bone diseases]] | [[Category:Bone diseases]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
Latest revision as of 19:40, 4 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Bone erosion | |
|---|---|
 | |
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Joint pain, swelling, stiffness |
| Complications | Joint deformity, loss of function |
| Onset | Gradual |
| Duration | Chronic |
| Types | N/A |
| Causes | Rheumatoid arthritis, psoriatic arthritis, gout, osteomyelitis |
| Risks | Genetic predisposition, smoking, obesity |
| Diagnosis | X-ray, MRI, ultrasound |
| Differential diagnosis | Osteoarthritis, osteoporosis |
| Prevention | Early treatment of underlying conditions |
| Treatment | Disease-modifying antirheumatic drugs (DMARDs), biologics, corticosteroids, physical therapy |
| Medication | Methotrexate, adalimumab, prednisone |
| Prognosis | Variable, depends on underlying condition and treatment |
| Frequency | Common in patients with inflammatory arthritis |
| Deaths | N/A |
Bone Erosion[edit]
Bone erosion refers to the loss of bone tissue, typically occurring in the context of inflammatory conditions such as rheumatoid arthritis (RA). It is characterized by the destruction of the bone surface, leading to structural damage and potential functional impairment.
Pathophysiology[edit]
Bone erosion is primarily driven by an imbalance between bone resorption and bone formation. In healthy bone, osteoclasts and osteoblasts work in harmony to remodel bone tissue. However, in pathological conditions, this balance is disrupted, often due to inflammatory processes. In rheumatoid arthritis, for example, the synovial membrane becomes inflamed, leading to the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 (IL-1). These cytokines stimulate osteoclastogenesis, the process by which osteoclasts are formed, leading to increased bone resorption and subsequent erosion.
Clinical Presentation[edit]
Patients with bone erosion may present with joint pain, swelling, and stiffness. Over time, the structural integrity of the affected bones can be compromised, leading to deformities and loss of function. In rheumatoid arthritis, common sites of bone erosion include the small joints of the hands and feet.
Diagnosis[edit]
Bone erosion is typically diagnosed using imaging techniques. X-ray is a common modality used to visualize bone erosions, as it can reveal changes in bone structure and density. More advanced imaging techniques, such as magnetic resonance imaging (MRI) and ultrasound, can provide more detailed information about the extent of erosion and associated soft tissue changes.
Management[edit]
The management of bone erosion involves addressing the underlying inflammatory condition. In rheumatoid arthritis, disease-modifying antirheumatic drugs (DMARDs) such as methotrexate are commonly used to reduce inflammation and slow the progression of bone damage. Biologic agents targeting specific cytokines, such as TNF inhibitors, can also be effective in preventing further erosion.
Prevention[edit]
Preventing bone erosion involves early diagnosis and aggressive treatment of the underlying inflammatory condition. Regular monitoring with imaging studies can help assess the effectiveness of treatment and guide adjustments in therapy.
